article thumbnail

: Curaleaf wins renewal for NJ licenses after emergency meeting of state’s cannabis regulatory commission

MarketWatch

after New Jersey Cannabis Regulatory Commission on Monday approved a renewal of the Massachusetts-based company’s cultivation and retail licenses for adult-use in the Garden State, in a reversal of a decision last week, according to spokespeople for the commission and Curaleaf. CURLFCA:CURA stock is up 4.2%

License 75
article thumbnail

: New York increases the number of conditional adult-use retail dispensary licenses to 300 from 150

MarketWatch

The New York State Office of Cannabis Management on Thursday said it’s increasing the number of conditional adult-use retail dispensary licenses to 300 from 150. At last check, the state has issued 66 provisional conditional adult-use retail dispensary (CAURD) licenses and four dispensaries have opened.

License 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

: Group of licensed medical cannabis operators file suit against New York regulator for failing to open licensing to all applicants at the same time

MarketWatch

A coalition of licensed medical cannabis operators has filed a lawsuit against the New York cannabis regulator, alleging it overstepped its authority and subverted the intent of the state legislature by failing to comply with provisions of the 2021 Marihuana Regulation and Taxation Act, or MRTA.

License 40
article thumbnail

: Curaleaf stock tumbles toward record low after NJ denies license renewal, but analyst sees case for company to appeal and sue

MarketWatch

toward a record low in morning trading Friday, in the wake of the decision by the New Jersey Cannabis Regulatory Commission (CRC Board) to deny the renewal of the Massachusetts-based company’s cultivation and retail licenses for adult use. “We CURLFCA:CURA tumbled 10.2%

License 40
article thumbnail

Resilient Consumers Have Not Saved Retail Stocks | Weekly Market Commentary | December 5, 2022

James Hendries

Economic and corporate data support the initial strong reads on holiday retail sales despite the macro headwinds, reinforcing the idea that today’s consumer is in a better position than usual at this point in the business cycle. Will a Resilient Consumer Support Holiday Retail?

Retail 52
article thumbnail

: Cannabis company Verano Q4 loss widens on impairment costs, but revenue climbs

MarketWatch

The Chicago-based cannabis company’s fourth-quarter loss includes a $229 million impairment charge, primarily of intangible assets related to its Arizona cultivation license and Pennsylvania and Arizona retail reporting units. Fourth-quarter revenue rose 7% to $225.93 million from $211.4 million, according to a survey by FacstSet.

License 75
article thumbnail

: Germany airs scaled-back plan to legalize cannabis for adult use through buyer clubs

MarketWatch

Officials said rules by the European Union on cannabis prevented a more widespread cannabis legalization plan to allow the sale of cannabis across the country at licensed retailers. The proposed new rules will legalize possession of up to 25 grams, or nearly one ounce, and allow individuals to grow three plants or less.